Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Herr
    Herr
  2. Vickers
    Vickers
  3. Russo
    Russo
  4. Scardino
    Scardino
  5. Eastham
    Eastham
  6. Jarnagin
    Jarnagin
  7. Reuter
    Reuter
  8. D'Angelica
    D'Angelica
  9. Kingham
    Kingham
  10. Ladanyi
    Ladanyi

Groups

  1. Surgery (2066)
  2. Department of Medicine (1341)
  3. Urology (1167)
  4. Solid Tumor Oncology Division (835)
  5. Population Sciences Research Program (825)
  6. Survivorship Research (720)
  7. Epidemiology and Biostatistics (691)
  8. Sloan Kettering Institute Faculty (603)
  9. Department of Pathology and Laboratory Medicine (590)
  10. GSK Faculty (583)
Search Within
Formats
  1. Journal Article (3915)
  2. Meeting Abstract (1050)
  3. Editorial (178)
  4. Review (139)
  5. Correspondence (120)
  6. Guidelines (83)
  7. Research Letter (31)
  8. Conference Paper (27)
  9. Book Section (5)
  10. Miscellaneous (3)
Groups
  1. Surgery (2066)
  2. Department of Medicine (1341)
  3. Urology (1167)
  4. Solid Tumor Oncology Division (835)
  5. Population Sciences Research Program (825)
  6. Survivorship Research (720)

More Groups

People
  1. Harry Herr (270)
  2. Andrew Vickers (228)
  3. Paul Russo (185)
  4. Peter Scardino (173)
  5. James Eastham (163)
  6. William Jarnagin (158)

More People

Years
  1. 2025 (146)
  2. 2024 (255)
  3. 2023 (235)
  4. 2022 (263)
  5. 2021 (233)
  6. 2020 (264)

More Years

Publications
  1. Journal of Urology (767)
  2. European Urology (578)
  3. Lancet Oncology (403)
  4. Urology (391)
  5. Journal of the American College of Surgeons (346)
  6. Journal of Molecular Diagnostics (276)

More Publications

Results (5551)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Exploring the association between varicocele and testosterone deficiency in men over 50 years of age
    Journal Article

    Kim, D. J.; Teloken, P. E.; Mulhall, J. P.
    Urology (2025)

    Fulltext@MSK | Save
  • Performance characteristics of an analytic model predicting retroperitoneal lymph node dissection pathology following first-line chemotherapy for patients with metastatic non-seminomatous germ cell tumors
    Journal Article

    Matulewicz, R. S.; Assel, M.; Vickers, A. J.; Jayalath, V. H.; Gold, S. A.; Funt, S. A.; Feldman, D. R.; Sheinfeld, J.
    Journal of Urology (2025)

    Fulltext@MSK | Save
  • The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment
    Journal Article

    Chan, S. L.; Sun, H. C.; Xu, Y.; Zeng, H.; El-Serag, H. B.; Lee, J. M.; Schwartz, M. E.; Finn, R. S.; Seong, J.; Wang, X. W.; more...
    Lancet (2025)

    Fulltext@MSK | Save
  • Predictors and patterns of non-urothelial recurrence after nephroureterectomy for upper tract urothelial carcinoma (UCAN Collaboration)
    Journal Article

    Katims, A. B.; Tin, A. L.; Assel, M.; Hensley, P.; Li, R.; Margulis, V.; Matin, S.; Pallauf, M.; Clark, R. K.; Raman, J. D.; more...
    Journal of Urology (2025)

    Fulltext@MSK | Save
  • CCR8 immunohistochemistry highlights CCR8 as a diagnostic and therapeutic biomarker in cutaneous T-cell lymphoma
    Research Letter

    Geller, S.; Liao, V.; Moy, A.; Hollmann, T. J.; Pulitzer, M.
    Journal of Investigative Dermatology (2025)

    Fulltext@MSK | Save
  • Cutaneous T-cell lymphoma after dupilumab treatment in patients with atopic dermatitis: A response letter to James et al
    Correspondence

    Geller, S.
    Journal of Investigative Dermatology (2025)

    Fulltext@MSK | Save
  • Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC
    Journal Article

    Rimassa, L.; Chan, S. L.; Sangro, B.; Lau, G.; Kudo, M.; Reig, M.; Breder, V.; Ryu, M. H.; Ostapenko, Y.; Sukeepaisarnjaroen, W.; more...
    Journal of Hepatology (2025)

    Fulltext@MSK | Save
  • Rethinking early detection: Magnetic resonance imaging strategies for smarter prostate cancer screening
    Editorial

    Carlsson, S. V.
    European Urology (2025)

    Fulltext@MSK | Save
  • First-line pembrolizumab plus lenvatinib for advanced non–clear-cell renal cell carcinoma: Updated results from the phase 2 KEYNOTE-B61 trial
    Journal Article

    Voss, M. H.; Gurney, H.; Atduev, V.; Suarez, C.; Climent, M. A.; Pook, D.; Tomczak, P.; Barthélémy, P.; Lee, J. L.; Nalbandian, T.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Irreversible electroporation for prostate tissue ablation in patients with intermediate-risk prostate cancer: Results from the PRESERVE trial
    Journal Article

    George, A. K.; Miocinovic, R.; Patel, A. R.; Lomas, D. J.; Correa, A. F.; Chen, D. Y. T.; Rastinehad, A. R.; Schwartz, M. J.; Sidana, A.; Stensland, K. D.; more...
    European Urology (2025)

    Fulltext@MSK | Save